5-(4-Pyridyl)-1,3,4-thiadiazol-2-yl-amine, 99.0%, 25g

Polyethylene Glycol Monododecyl Ether (n=approx. 25) [for Biochemical Research]5g

(E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride (Doxepin Impurity), 97%, 25mg

Fmoc-(S)-3-Amino-4-(1-naphthyl)-butyric acid, 97%, 1g

(2S,3S)-2-(5-(Dimethylamino)naphthalene-1-sulfonamido)-3-methylpentanoic acid, 100mg

(S)-tert-Butyl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-aminohexanoate hydrochloride, 98%, 10g

5,12-Bis((triisopropylsilyl)ethynyl)tetracene, 97%, 250mg

5-Amino-1-(3-chlorophenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 100g

3-piperazin-1-yl-6-pyridin-4-ylpyridazine, 95.0%, 500mg

4-Bromo-6-nitro-1H-indazole, 95.0%, 1g

(1R,2R,3R,4S,5R,6S,7S,8S)-methyl 4-bromocubane-1-carboxylate, 98%, 500mg

4,4',4'',4'''-Methanetetrayltetraaniline, 95.0%, 10g

4-Trimethylsilyl-3-butyn-2-ol>97.0%(GC)5g